IP Library › Granted Patent US 11,213,670
Granted Patent B2
US 11,213,670 · App. 16/296,863 · Granted Jan 4, 2022

Ventricular assist device and cardiac electrical stimulation system for therapy control

Inventor: Mark L. Brown (North Oaks, MN)
Assignee: Medtronic, Inc.
A61M60/148A61B5/4836A61M60/00A61M60/50A61N1/3627A61N1/36514A61N1/3754A61N1/3904A61N1/3956A61N1/3962A61B5/363A61N1/37288A61N1/37512A61N1/3925
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,213,670
App. No.
16/296,863
Granted
Jan 4, 2022
Kind
B2
Abstract

A medical device system includes a cardiac electrical stimulation device and a ventricular assist device (VAD). The cardiac stimulation device and the VAD are capable of communication with each other to confirm detection of cardiac events.

Claims (33)

1. A device comprising:

a sensing circuit configured to receive a cardiac electrical signal;

a therapy delivery circuit configured to deliver an electrical stimulation therapy;

a telemetry circuit configured for communication with a ventricular assist device (VAD); and

a control circuit coupled to the sensing circuit, the therapy delivery circuit and the telemetry circuit and configured to:

detect a tachyarrhythmia event from the cardiac electrical signal received by the sensing circuit;

receive via the telemetry circuit a signal transmitted by the VAD;

in response to detecting the tachyarrhythmia event, select a therapy delivery response based on the received signal transmitted by the VAD; and

control the therapy delivery circuit according to the selected therapy delivery response.

2. The device of claim 1 , wherein the control circuit is further configured to control the telemetry circuit to transmit, in response to detecting the tachyarrhythmia event, a request signal to the VAD to trigger transmission of the signal by the VAD, wherein the signal transmitted by the VAD comprises a confirmation signal for confirming the tachyarrhythmia event.

3. The device of claim 2 , wherein the control circuit is configured to control the therapy delivery circuit to start delivering anti-tachycardia pacing after transmitting the request signal and prior to receiving the confirmation signal.

4. The device of claim 2 , wherein the control circuit is configured to control the therapy delivery circuit to start charging a high voltage capacitor after transmitting the request signal and prior to receiving the confirmation signal.

5. The device of claim 1 , wherein the control circuit is configured to detect the tachyarrhythmia event by detecting a shockable rhythm.

6. The device of claim 1 , wherein the control circuit is configured to select the therapy delivery response based on the received signal transmitted by the VAD by one of:

scheduling a shock therapy in response to the signal transmitted by the VAD indicating a shockable flow condition detected by the VAD, or

withholding a shock therapy in response to the signal transmitted by the VAD indicating a non-shockable flow condition detected by the VAD.

7. The device of claim 1 , wherein the control circuit is configured to select the therapy delivery response by withholding an electrical stimulation therapy based on the received signal transmitted by the VAD not confirming the detected tachyarrhythmia event.

8. The device of claim 1 , wherein the control circuit is configured to select the therapy delivery response by controlling the therapy delivery circuit to deliver an electrical stimulation therapy based on the signal transmitted by the VAD confirming the detected tachyarrhythmia event.

9. A method comprising:

obtaining a cardiac electrical signal;

detecting a tachyarrhythmia event from the cardiac electrical signal;

receiving a signal transmitted from a ventricular assist device (VAD);

in response to detecting the tachyarrhythmia event, selecting a therapy delivery response based on the received signal transmitted from the VAD; and

controlling the therapy delivery circuit according to the selected therapy delivery response.

10. The method of claim 9 , further comprising transmitting, in response to detecting the tachyarrhythmia event, a request signal to the VAD to trigger transmission of the signal from the VAD, wherein the signal transmitted from the VAD comprises a confirmation signal for confirming the tachyarrhythmia event.

11. The method of claim 10 , further comprising starting delivery of anti-tachycardia pacing after transmitting the request signal and prior to receiving the confirmation signal.

12. The method of claim 10 , further comprising starting charging of a high voltage capacitor after transmitting the request signal and prior to receiving the confirmation signal.

13. The method of claim 9 , wherein detecting the tachyarrhythmia event comprises detecting a shockable cardiac rhythm.

14. The method of claim 9 , wherein selecting the therapy delivery response comprises one of:

scheduling a shock therapy in response to the signal transmitted from the VAD indicating a shockable flow condition detected by the VAD, or

withholding a shock therapy in response to the signal transmitted from the VAD indicating a non-shockable flow condition detected by the VAD.

15. The method of claim 9 , wherein selecting the therapy delivery response comprises withholding an electrical stimulation therapy based on the received signal transmitted by the VAD not confirming the detected tachyarrhythmia event.

16. The method of claim 9 , wherein selecting the therapy delivery response comprises controlling the therapy delivery circuit to deliver an electrical stimulation therapy based on the signal transmitted from the VAD confirming the detected tachyarrhythmia event.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2019
From: BROWN, MARK L.
To: MEDTRONIC, INC. (CVG)
Reel/Frame 048557/0600 →
Continuity (2)
Provisional Application 62640834 · Mar 9, 2018
Related Publication 20190275225A1 · Sep 12, 2019